The penicillin dosage for acute urethral gonorrhoea in males varies not only in different parts of the world but also in different parts of the country. There is a spiral of increasing one-shot dosage which is set in motion by an increasing failure rate. Before 1957 the dose was usually restricted to 0 3 mega units of an aqueous or oily suspension of procaine penicillin or of procaine penicillin in oil with 2 per cent. aluminium monostearate (PAM). Today 2 4 mega units is a not unusual dose.
In Sheffield we have not yet arrived at this exalted twist of the spiral. In 1960 the routine dose was increased to 0-6 mega units of aqueous procaine penicillin, but with a relapse rate which is again rising it behoves us to assess the relapses from the clinical and laboratory point of view. A correlation between increasing failure rate and decreasing sensitivity of the gonococcus to penicillin has been reported from various centres (WHO, 1963) 
Discussion
The difficulty of differentiating between relapse and re-infection is too well known to be laboured; the criteria for relapses previously described have been strictly followed. The smallness of the number of relapses (only 88 in all) must of necessity restrict the validity of the investigation. The purpose of the investigation was to see whether relapse in acute gonococcal urethritis in the male could be foreseen on clinical grounds. It would seem that the coexistence of posterior urethritis is not more common in the failures than in the successes.
Prolonged duration of infection, however, is commoner in the relapses than in the successes, particularly in more recent years. In view of this finding it is possible that treatment for acute gonorrhoea in the male of comparatively long standing should be more intensive than for that of short duration. 
